Landmark Trial Validates Integrative Medicine for Anaemia

The News:
Results from a massive, multi-center Phase III Randomized Controlled Trial (RCT) involving 4,000 participants show that specialized, standardized Ayurvedic formulations are therapeutically non-inferior to standard Iron Folic Acid (IFA) therapies in managing Iron Deficiency Anaemia.

Why it Matters:
This trial sets an important precedent for “Integrative Clinical Trials.” Subjecting traditional, plant-derived therapies to rigorous, large-scale Phase III protocols under strict regulatory oversight paves the way for diversified, globally accepted holistic drug validation frameworks.